Bone marrow and blood stem cell transplant survival rates equal, when donor is …EurekAlert (press release)Patients who receive a blood stem cell transplant from a donor outside of their family to treat leukemia and other blood diseases are more likel…
Seattle Genetics and Millennium Highlight Pivotal Data on ADCETRIS … – TradersHuddle.com (press release)
SunHerald.comSeattle Genetics and Millennium Highlight Pivotal Data on ADCETRIS …TradersHuddle.com (press release)ADCETRIS was granted accelerated approval by the US Food and Drug Administration in August 2011 for two indications: (1) the treatment o…
Weaning transplant recipients from their immunosuppressive drugs – EurekAlert (press release)
Weaning transplant recipients from their immunosuppressive drugsEurekAlert (press release)Transplant surgeons live in the hope that one day they will be able to wean at least some of their patients off the immunosuppressive drugs that must be taken to …
Man who survived multiple organ failure opens new business – Your Local Guardian
Man who survived multiple organ failure opens new businessYour Local GuardianA man who defied the odds to survive multiple organ failure whilst on holiday in Mexico has just opened a new 'shabby chic' furniture shop in Stoneleigh. Gary Nader, f…
Toxicity Without Benefit With Paclitaxel Plus Everolimus – Medscape
Toxicity Without Benefit With Paclitaxel Plus EverolimusMedscapeDecember 12, 2011 (San Antonio, Texas) — It seemed like a good idea at the time, but including everolimus (Afinitor, Novartis) in a neoadjuvant chemotherapy regimen with paclitaxel (Taxo…
Fractionated 90 Y-Ibritumomab Tiuxetan Effective as First-Line Therapy for … – Monthly Prescribing Reference
Fractionated 90 Y-Ibritumomab Tiuxetan Effective as First-Line Therapy for …Monthly Prescribing ReferencePatients with >20% bone marrow (BM) involvement received fractionated RIT only if a repeat BM biopsy demonstrated a reduction to ≤20% involv…
Wellpoint: Oppenheimer Funds' Largest Healthcare Stock Holding in Q3 – Wall St. Cheat Sheet
Wellpoint: Oppenheimer Funds' Largest Healthcare Stock Holding in Q3Wall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejec…
Breast cancer victims 'can double survival time' – Trade Arabia
Breast cancer victims 'can double survival time'Trade ArabiaWomen suffering from breast cancer can survive for twice as long without disease progression using the Novartis-made drug Afinitor (everolimus) in conjunction with hormonal therapy, sa…
Excellent PFS and OS Observed with CHOP Combination Regimens in Newly … – Monthly Prescribing Reference
Excellent PFS and OS Observed with CHOP Combination Regimens in Newly …Monthly Prescribing ReferenceThe CHOP-R arm of patients received six cycles of CHOP chemotherapy (cyclophosphamide 750mg/m 2 , doxorubicin 50mg/m 2 , vincristine 1.4mg/m 2 , and p…
Celladon Corporation Receives FDA Fast Track Designation for Its … – PR Newswire (press release)
Celladon Corporation Receives FDA Fast Track Designation for Its …PR Newswire (press release)"The positive results of the phase 2 CUPID Trial demonstrated the potential of MYDICAR® to become an important treatment for patients with chronic, adv…